CAS 521079-87-8

Tefibazumab

CAS : 521079-87-8

Humanized monoclonal antibody targeting Clumping factor A; treatment of Staphylococcus aureus

Ref: 3D-CLA1200

Tefibazumab

CAS : 521079-87-8

Tefibazumab is a humanised monoclonal antibody targeting ClfA (clumping factor A), indicated for the treatment of Staphylococcus aureus bacteraemia.

Degré de pureté : 95% - 98.2% (SDS-PAGE); 96.8% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : 147.02 kDa

Ref: TM-T81024